- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-04-02-2011
Pharmaceutical Technology
Pharmaceutical Technology North America, April 2011
April 02, 2011
Issue PDF
35
4
Solid Dosage and Excipients
In the Spotlight April 2011
April 02, 2011
In the Spotlight
35
4
Editor's picks of analytical instrumentation products for April 2011.
Global Healthcare on the Ground: Framework Set for Supply-Chain Improvement
April 02, 2011
News
35
4
PRTM helps to improve supply-chain management and logistics in developing countries.
Health-Reform Controversies
April 02, 2011
Washington Report
35
4
Courts and Congress seek to reshape policies and programs.
Biotechnology Loses Lead in Funding
April 02, 2011
BioForum
35
4
An uncertain regulatory environment affects funding for biotechnology.
Celebrity Couples to Disunite
April 02, 2011
From The Editor
35
4
Research and development may be headed for divorce.
Report From China
April 02, 2011
News
35
4
The contract-research industry in China is growing in leaps and bounds, and Big Pharma is leading the way.
FDA Perspectives: Common Deficiences in Abbreviated New Drug Applications (Part 4)
April 02, 2011
Special Feature
35
4
FDA reviewers aim to assist ANDA sponsors in building quality into their submissions by clarifying components of the applications. Part 4 addresses manufacture and container closure.
Scrutinizing the Subvisible
April 02, 2011
Special Report
35
4
Regulators question whether particles that they can't see hurt patients.
Advancing Small-Molecule Synthesis
April 02, 2011
Ingredients Insider
35
4
Chemocatalytic and biocatalytic routes play an important role in improving the manufacture of intermediates and active pharmaceutical ingredients.
PCMO Initiative Gathers Strength
April 02, 2011
Inside PDA
35
4
A review of current efforts within PDA's Paradigm Change in Manufacturing Operations initiative.
Revisiting Interventions in Aseptic Processing
April 02, 2011
Special Feature
35
4
The authors revisit their previous effort to refine the terms that describe interventions and to dispel confusion that arose after the original article was published.
A Hard Look at Third-Party External Supply Networks
April 02, 2011
Outsourcing Outlook
35
4
The complexity of third-party external supply networks requires new ways to manage them.
Inspections Gone Mad
April 02, 2011
Agent-in Place
35
4
In any industry, inspections can be a pain, and pharma is no exception.
US Steps Up Scrutiny of Foreign Transactions
April 02, 2011
Special Report
35
4
Companies engaged in global mergers and acquisitions may be hearing from the Department of Justice more often to ensure that corruptive practices are not taking place.
Delivering Tamoxifen within Solid Lipid Nanoparticles
April 02, 2011
Peer-Reviewed Research
35
4
The aim of this study was to prepare and characterize physiochemically and biologically tamoxifen-loaded SLNs to evaluate their effectiveness as a drug-delivery system to treat breast cancers.
A QbD World for Suppliers
April 02, 2011
PharmTech Talk
35
4
The need for greater process understanding raises the bar for suppliers.
Pitfalls in Statistics
April 02, 2011
Statistical Solutions
35
4
The hardest errors to spot are the ones that don't look like errors at all.
Q&A with Bob Weaver, HunterLab
April 02, 2011
Industry Leaders
35
4
Bob Weaver, president of HunterLab, discusses current trends and challenges.